# Prescription of Letrozole for Uterine Myoma

> **NCT06143631** · PHASE4 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 140 (estimated)

## Conditions studied

- Leiomyoma, Uterine
- Leiomyoma
- Fibroid
- Fibroid Uterus

## Interventions

- **DRUG:** Letrozole 2.5mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06143631
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-24
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143631, "Prescription of Letrozole for Uterine Myoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06143631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*